The great epidemiological relevance of the overactive bladder (OAB) syndrome and its impact on quality of life of sufferers has encouraged a growing amount of research both in basic science and in clinical fields, with the pharmacological treatment of OAB syndrome being particularly investigated. Recently a new perspective for the use of alpha-lytic drugs in the treatment of OAB syndrome has been disclosed due to encouraging anecdotal data, and to the identification of different adrenoceptor subtypes in the female lower urinary tract. Starting with a reference picture of female lower urinary tract disorders, the authors review the present pharmacological treatment of female lower urinary tract disorders, and delineate the new perspectives acquired from recent studies of adrenoceptor subtypes.

Salvatore, S., Soligo, M., Proietti, F., Citterio, S., Artibani, W., Milani, R. (2005). Overactive bladder syndrome: considerations in pharmacotherapy and new perspectives. EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY, 120(2), 129-133 [10.1016/j.ejogrb.2004.10.014].

Overactive bladder syndrome: considerations in pharmacotherapy and new perspectives

MILANI, RODOLFO
2005

Abstract

The great epidemiological relevance of the overactive bladder (OAB) syndrome and its impact on quality of life of sufferers has encouraged a growing amount of research both in basic science and in clinical fields, with the pharmacological treatment of OAB syndrome being particularly investigated. Recently a new perspective for the use of alpha-lytic drugs in the treatment of OAB syndrome has been disclosed due to encouraging anecdotal data, and to the identification of different adrenoceptor subtypes in the female lower urinary tract. Starting with a reference picture of female lower urinary tract disorders, the authors review the present pharmacological treatment of female lower urinary tract disorders, and delineate the new perspectives acquired from recent studies of adrenoceptor subtypes.
Articolo in rivista - Articolo scientifico
Male; Muscle Contraction; Menopause; Adrenergic alpha-Antagonists; Female; Cholinergic Antagonists; Imipramine; Urinary Incontinence; Muscle, Smooth; Estrogen Replacement Therapy; Humans
English
1-giu-2005
120
2
129
133
none
Salvatore, S., Soligo, M., Proietti, F., Citterio, S., Artibani, W., Milani, R. (2005). Overactive bladder syndrome: considerations in pharmacotherapy and new perspectives. EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY, 120(2), 129-133 [10.1016/j.ejogrb.2004.10.014].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/14639
Citazioni
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 5
Social impact